MARC Record from marc_columbia

LEADER: 04017cam a22003973a 4500
001 6952186
005 20221130194724.0
008 080709t20082008nyu 001 0 eng d
010 $a 2008931003
016 7 $aB0812007$2bccb
020 $a9781402086953
020 $a1402086954
029 1 $aNLGGC$b314439307
029 1 $aAU@$b000043498253
035 $a(OCoLC)ocn233933805
035 $a(NNC)6952186
035 $a(OCoLC)233933805
035 $a6952186
040 $aBTCTA$cBTCTA$dBAKER$dNLGGC$dYDXCP$dCUS$dOrLoB-B
060 4 $aWN 450 T185 2008
245 00 $aTargeted radionuclide tumor therapy :$bbiological aspects /$cTorgny Stigbrand, Jörgen Carlsson, Gregory P. Adams, editors.
260 $a[New York?] :$bSpringer,$c[2008], ©2008.
300 $axiii, 402 pages :$billustrations (some color), color portraits ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $g1.$tIntroduction to Radionuclide Therapy /$rJorgen Carlsson, Torgny Stigbrand and Gregory P. Adams -- $g2.$tTherapeutically Used Targeted Antigens in Radioimmunotherapy /$rTorgny Stigbrand, David Eriksson, Katrine Riklund and Lennart Johansson -- $g3.$tEGFR-Family Expression and Implications for Targeted Radionuclide Therapy /$rJorgen Carlsson -- $g4.$tTargeting Tumours with Radiolabeled Antibodies /$rTorgny Stigbrand, David Eriksson, Katrine Riklund and Lennart Johansson -- $g5.$tAntibody Fragments Produced by Recombinant and Proteolytic Methods /$rGregory P. Adams -- $g6.$tNovel Alternative Scaffolds and Their Potential Use for Tumor Targeted Radionuclide Therapy /$rFredrik Y. Frejd -- $g7.$tPeptides for Radionuclide Therapy /$rMarion de Jong, Suzanne M. Verwijnen, Monique de Visser, Dik J. Kwekkeboom, Roelf Valkema and Eric P. Krenning -- $g8.$tChoice of Radionuclides and Radiolabelling Techniques /$rVladimir Tolmachev -- $g9.$tHigh-LET-Emitting Radionuclides for Cancer Therapy /$rGeorge Sgouros -- $g10.$tTargeted High-LET Therapy of Bone Metastases /$rOyvind S. Bruland, Dahle Jostein, Dag Rune Olsen and Roy H. Larsen -- $g11.$tThe Auger Effect in Molecular Targeting Therapy /$rHans Lundqvist, Bo Stenerlow and Lars Gedda -- $g12.$tRadiation Induced Cell Deaths /$rDavid Eriksson, Katrine Riklund, Lennart Johansson and Torgny Stigbrand -- $g13.$tRadiation Induced DNA-Damage/Repair and Associated Signaling Pathways /$rBo Stenerlow, Lina Ekerljung, Jorgen Carlsson and Johan Lennartsson -- $g14.$tRadiation Induced DNA Damage Checkpoints /$rDavid Eriksson, Katrine Riklund, Lennart Johansson and Torgny Stigbrand -- $g15.$tCancer Stem Cells and Radiation /$rDavid Eriksson, Katrine Riklund, Lennart Johansson and Torgny Stigbrand -- $g16.$tEffects of Low Dose-Rate Radiation on Cellular Survival /$rJorgen Carlsson -- $g17.$tBystander Effects and Radionuclide Therapy /$rKevin M. Prise -- $g18.$tEnhancing the Efficiency of Targeted Radionuclide Therapy /$rGregory P. Adams -- $g19.$tLow Dose Hyper-Radiosensitivity: A Historical Perspective /$rBrian Marples, Sarah A. Krueger, Spencer J. Collis and Michael C. Joiner -- $g20.$tClinical Radionuclide Therapy /$rAndrew M. Scott and Sze-Ting Lee -- $g21.$tDevelopmental Trends in Targeted Radionuclide Therapy: Biological Aspects /$rTorgny Stigbrand, Jorgen Carlsson and Gregory P. Adams.
650 0 $aTumors$xTreatment.
650 0 $aNuclear medicine.$0http://id.loc.gov/authorities/subjects/sh85093011
650 2 $aNeoplasms$xtherapy.$0https://id.nlm.nih.gov/mesh/D009369Q000628
650 2 $aRadioisotopes$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D011868Q000627
650 2 $aAntibodies$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D000906Q000627
700 1 $aStigbrand, Torgny.$0http://id.loc.gov/authorities/names/n84084799
700 1 $aCarlsson, Jörgen,$d1960-$0http://id.loc.gov/authorities/names/nb2008021049
700 1 $aAdams, Gregory P.$0http://id.loc.gov/authorities/names/nb2008021052
852 00 $boff,hsl$hRC257$i.T18 2008